MSTN and type 1 diabetes mellitus: These results demonstrate that the STZ model substantially impairs vascular endothelial function in skeletal muscle, similar to humans experiencing poorly managed T1D, and that myostatin deletion can serve as a buffer to protect against vascular dysfunction, preserving overall cardiovascular and skeletal muscle function.